Edan Instruments, Inc. (SHE:300206)

Market Cap	7.47B
Revenue (ttm)	1.90B
Net Income (ttm)	246.84M
Shares Out	579.66M
EPS (ttm)	0.43
PE Ratio	30.27
Forward PE	n/a
Dividend	0.21 (1.60%)
Ex-Dividend Date	May 27, 2025

Volume	3,444,300
Average Volume	5,383,452
Open	13.07
Previous Close	12.89
Day's Range	12.75 - 13.07
52-Week Range	9.55 - 14.93
Beta	0.55
RSI	43.73
Earnings Date	Apr 16, 2026

About Edan Instruments

Edan Instruments, Inc. engages in the research, development, manufacture, and service of medical electronic equipment and in vitro diagnostic products in China and internationally. The company offers ECG products, including resting ECG, stress test, holter, wireless solution, and ECG workstation products; patient monitoring systems, such as modular and compact patient monitor, vital signs, and telemetry and IT products; and obstetrics and gynecology products comprising fetal and maternal monitoring systems, fetal telemetry systems, ultrasonic d...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1995
• Employees: 2,546
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300206

Financial Performance

In 2024, Edan Instruments's revenue was 1.83 billion, a decrease of -5.35% compared to the previous year's 1.94 billion. Earnings were 162.11 million, a decrease of -26.75%.